Summary

The global Gastrointestinal Bleeding Therapeutic Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Gastrointestinal Bleeding Therapeutic Devices market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
CONMED Corporation
Olympus Corporation
Boston Scientific Corporation
Cook Medical
Abbott
Cardinal Health
Morrris Innovative
US Medical Innovations (US Patent Innovations)
Ovesco Endoscopy
Segment by Type
Endoscopic Hemostatic Devices
Closure Devices
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Gastrointestinal Bleeding Therapeutic Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Gastrointestinal Bleeding Therapeutic Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Gastrointestinal Bleeding Therapeutic Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Endoscopic Hemostatic Devices
1.2.3 Closure Devices
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Gastrointestinal Bleeding Therapeutic Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Gastrointestinal Bleeding Therapeutic Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Gastrointestinal Bleeding Therapeutic Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Gastrointestinal Bleeding Therapeutic Devices Sales Estimates and Forecasts 2020-2031
2.4 Global Gastrointestinal Bleeding Therapeutic Devices Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Gastrointestinal Bleeding Therapeutic Devices Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Gastrointestinal Bleeding Therapeutic Devices Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Endoscopic Hemostatic Devices Market Size by Manufacturers
3.5.2 Closure Devices Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Gastrointestinal Bleeding Therapeutic Devices Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Gastrointestinal Bleeding Therapeutic Devices Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Gastrointestinal Bleeding Therapeutic Devices Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Gastrointestinal Bleeding Therapeutic Devices Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Gastrointestinal Bleeding Therapeutic Devices Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Type (2020-2031)
6.4 North America Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Gastrointestinal Bleeding Therapeutic Devices Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Type (2020-2031)
7.4 Europe Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Gastrointestinal Bleeding Therapeutic Devices Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Gastrointestinal Bleeding Therapeutic Devices Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Type (2020-2031)
9.4 Central and South America Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Gastrointestinal Bleeding Therapeutic Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Gastrointestinal Bleeding Therapeutic Devices Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Gastrointestinal Bleeding Therapeutic Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 CONMED Corporation
11.1.1 CONMED Corporation Corporation Information
11.1.2 CONMED Corporation Business Overview
11.1.3 CONMED Corporation Gastrointestinal Bleeding Therapeutic Devices Product Models, Descriptions and Specifications
11.1.4 CONMED Corporation Gastrointestinal Bleeding Therapeutic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 CONMED Corporation Gastrointestinal Bleeding Therapeutic Devices Sales by Product in 2024
11.1.6 CONMED Corporation Gastrointestinal Bleeding Therapeutic Devices Sales by Application in 2024
11.1.7 CONMED Corporation Gastrointestinal Bleeding Therapeutic Devices Sales by Geographic Area in 2024
11.1.8 CONMED Corporation Gastrointestinal Bleeding Therapeutic Devices SWOT Analysis
11.1.9 CONMED Corporation Recent Developments
11.2 Olympus Corporation
11.2.1 Olympus Corporation Corporation Information
11.2.2 Olympus Corporation Business Overview
11.2.3 Olympus Corporation Gastrointestinal Bleeding Therapeutic Devices Product Models, Descriptions and Specifications
11.2.4 Olympus Corporation Gastrointestinal Bleeding Therapeutic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Olympus Corporation Gastrointestinal Bleeding Therapeutic Devices Sales by Product in 2024
11.2.6 Olympus Corporation Gastrointestinal Bleeding Therapeutic Devices Sales by Application in 2024
11.2.7 Olympus Corporation Gastrointestinal Bleeding Therapeutic Devices Sales by Geographic Area in 2024
11.2.8 Olympus Corporation Gastrointestinal Bleeding Therapeutic Devices SWOT Analysis
11.2.9 Olympus Corporation Recent Developments
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Corporation Information
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Gastrointestinal Bleeding Therapeutic Devices Product Models, Descriptions and Specifications
11.3.4 Boston Scientific Corporation Gastrointestinal Bleeding Therapeutic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Boston Scientific Corporation Gastrointestinal Bleeding Therapeutic Devices Sales by Product in 2024
11.3.6 Boston Scientific Corporation Gastrointestinal Bleeding Therapeutic Devices Sales by Application in 2024
11.3.7 Boston Scientific Corporation Gastrointestinal Bleeding Therapeutic Devices Sales by Geographic Area in 2024
11.3.8 Boston Scientific Corporation Gastrointestinal Bleeding Therapeutic Devices SWOT Analysis
11.3.9 Boston Scientific Corporation Recent Developments
11.4 Cook Medical
11.4.1 Cook Medical Corporation Information
11.4.2 Cook Medical Business Overview
11.4.3 Cook Medical Gastrointestinal Bleeding Therapeutic Devices Product Models, Descriptions and Specifications
11.4.4 Cook Medical Gastrointestinal Bleeding Therapeutic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Cook Medical Gastrointestinal Bleeding Therapeutic Devices Sales by Product in 2024
11.4.6 Cook Medical Gastrointestinal Bleeding Therapeutic Devices Sales by Application in 2024
11.4.7 Cook Medical Gastrointestinal Bleeding Therapeutic Devices Sales by Geographic Area in 2024
11.4.8 Cook Medical Gastrointestinal Bleeding Therapeutic Devices SWOT Analysis
11.4.9 Cook Medical Recent Developments
11.5 Abbott
11.5.1 Abbott Corporation Information
11.5.2 Abbott Business Overview
11.5.3 Abbott Gastrointestinal Bleeding Therapeutic Devices Product Models, Descriptions and Specifications
11.5.4 Abbott Gastrointestinal Bleeding Therapeutic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Abbott Gastrointestinal Bleeding Therapeutic Devices Sales by Product in 2024
11.5.6 Abbott Gastrointestinal Bleeding Therapeutic Devices Sales by Application in 2024
11.5.7 Abbott Gastrointestinal Bleeding Therapeutic Devices Sales by Geographic Area in 2024
11.5.8 Abbott Gastrointestinal Bleeding Therapeutic Devices SWOT Analysis
11.5.9 Abbott Recent Developments
11.6 Cardinal Health
11.6.1 Cardinal Health Corporation Information
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Gastrointestinal Bleeding Therapeutic Devices Product Models, Descriptions and Specifications
11.6.4 Cardinal Health Gastrointestinal Bleeding Therapeutic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Cardinal Health Recent Developments
11.7 Morrris Innovative
11.7.1 Morrris Innovative Corporation Information
11.7.2 Morrris Innovative Business Overview
11.7.3 Morrris Innovative Gastrointestinal Bleeding Therapeutic Devices Product Models, Descriptions and Specifications
11.7.4 Morrris Innovative Gastrointestinal Bleeding Therapeutic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Morrris Innovative Recent Developments
11.8 US Medical Innovations (US Patent Innovations)
11.8.1 US Medical Innovations (US Patent Innovations) Corporation Information
11.8.2 US Medical Innovations (US Patent Innovations) Business Overview
11.8.3 US Medical Innovations (US Patent Innovations) Gastrointestinal Bleeding Therapeutic Devices Product Models, Descriptions and Specifications
11.8.4 US Medical Innovations (US Patent Innovations) Gastrointestinal Bleeding Therapeutic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 US Medical Innovations (US Patent Innovations) Recent Developments
11.9 Ovesco Endoscopy
11.9.1 Ovesco Endoscopy Corporation Information
11.9.2 Ovesco Endoscopy Business Overview
11.9.3 Ovesco Endoscopy Gastrointestinal Bleeding Therapeutic Devices Product Models, Descriptions and Specifications
11.9.4 Ovesco Endoscopy Gastrointestinal Bleeding Therapeutic Devices Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Ovesco Endoscopy Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Gastrointestinal Bleeding Therapeutic Devices Industry Chain
12.2 Gastrointestinal Bleeding Therapeutic Devices Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Gastrointestinal Bleeding Therapeutic Devices Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Gastrointestinal Bleeding Therapeutic Devices Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Gastrointestinal Bleeding Therapeutic Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Gastrointestinal Bleeding Therapeutic Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details